image
Healthcare - Biotechnology - NASDAQ - US
$ 1.17
-7.14 %
$ 6.9 M
Market Cap
-0.38
P/E
BALANCE SHEET
11.4 M ASSETS
-52.29%
12.7 M LIABILITIES
-26.90%
-1.35 M EQUITY
-20.92%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Plus Therapeutics, Inc.
image
Current Assets 9.83 M
Cash & Short-Term Investments 8.55 M
Receivables 0
Other Current Assets 1.28 M
Non-Current Assets 1.55 M
Long-Term Investments 0
PP&E 1.11 M
Other Non-Current Assets 446 K
Current Liabilities 10.7 M
Accounts Payable 4.76 M
Short-Term Debt 4.1 M
Other Current Liabilities 1.87 M
Non-Current Liabilities 2.01 M
Long-Term Debt 85 K
Other Non-Current Liabilities 1.92 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
ASSETS
Cash & Cash Equivalents 8.6 18.1 18.4 8.3 17.6 5.3 9.6 12.6 14.3 14.6 15.5 25.7 36.9 52.7 12.9 12.6 11.5 8.9 8.0 2.8 2.8 5.1 2.7 7.5 2.5 35 K
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.0 7.8 10.6 11.4 19.9 31.3 37.0 0 0
Receivables 0 0 7 K 59 K 1.2 0.2 0.1 1.2 1.3 1.4 4.3 4.0 2.5 2.2 2.0 1.9 75 K 0.3 0.9 0.9 1.3 1.2 0.5 0.7 0 0
Inventory 0 0 7 K 59 K 0.1 0.1 3.2 3.7 4.3 4.8 3.7 3.2 3.3 3.4 2.6 2.1 0 0.2 0.3 0.4 0.8 1.1 1.7 2.3 0 0
Other Current Assets 1.3 3.7 1.3 0.8 1.0 4.0 2.0 1.2 2.5 1.7 1.2 1.1 0.6 0.7 0.6 0.6 0.7 0.6 0.6 0.9 0.5 0.8 0.9 0.9 0 0
Total Current Assets 9.8 21.8 19.7 9.2 19.8 9.6 14.9 18.7 21.2 21.7 24.6 34.0 43.3 59.0 18.1 17.2 12.2 14.0 17.5 15.6 16.9 28.2 37.0 48.3 2.5 35 K
PP&E 1.1 1.6 1.8 2.5 3.0 2.3 3.1 1.2 1.6 1.6 1.1 2.2 1.7 1.7 1.3 2.6 3.4 4.2 4.3 3.1 3.8 3.6 5.2 3.7 0 0
Intangible Assets 42 K 94 K 51 K 86 K 0 6.0 7.2 8.4 9.0 9.4 9.3 0 0.2 0.4 0.6 0.9 1.1 1.3 5.9 6.5 2.4 6.9 0 0 0 0
Goodwill 0.4 0.4 0.4 0.4 0.4 0.4 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 4.4 4 387.0 4 387.0 4.6 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0.3 0 0 85 K 0.2 0.5 0.3 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 32 K 12 K 16 K 16 K 72 K 11.7 2.6 2.3 1.9 2.1 3.2 3.1 2.1 0.9 0.5 1.1 0.8 1.0 0.5 0.2 0.3 0.6 1.0 0.2 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 11.4 23.9 22.0 12.1 23.2 24.0 31.6 34.6 37.7 38.7 42.1 43.2 51.5 66.3 24.7 25.6 21.5 24.9 28.2 25.5 28.1 39.3 43.1 52.3 5.6 1.0
LIABILITIES
Accounts Payable 4.8 8.4 2.6 0.8 0.3 0.7 1.3 1.3 1.0 0.9 1.0 1.6 0.3 (5 512.0) 1.1 0.5 0.5 0.7 0.9 0.5 0 (19.4) (900.7) 0 0 0
Short Term Debt 4.1 1.8 1.8 6.5 11.3 14.2 13.6 6.6 0 7.4 3.2 19.6 2.5 6.5 2.7 2.0 0.7 1.0 1.0 0.9 1.4 0.4 0.7 0.1 0 0
Other Current Liabilities 1.9 1.7 1.4 1.3 2.8 2.6 3.5 4.3 7.2 7.4 10.6 (3.6) 5.1 5 518.8 4.3 4.6 6.9 4.9 5.2 1.8 3.0 21.9 901.8 1.4 0 0
Total Current Liabilities 10.7 11.9 5.9 8.5 14.5 17.6 18.4 12.5 8.4 15.9 14.9 17.6 7.8 13.2 8.2 7.1 8.1 6.6 7.1 3.3 4.5 2.9 1.8 1.5 0 0
Long Term Debt 85 K 3.9 5.3 0.5 0.6 0 0 11.0 16.7 18.0 23.1 12.9 22.0 13.3 5.6 5.0 0.2 1.2 1.6 1.1 1.2 770.0 1.9 0.3 0 0.2
Deferred Tax Income 0 (1.6) 0 0 0 0 0 0 0 0 0 0 0 (13.3) 0 (2 445.0) (2 379.0) (2 389.0) (2 541.0) (1 092.0) (7 539.0) (9 642.0) 0 0 0 0
Other Liabilities 1.9 1.6 1 K 7 K 6.9 1.0 0.1 17 K 0.4 10.5 0.9 2.2 2.5 6.2 4.6 2.1 1.0 0.9 5.3 0 0 (769.2) 0.9 1.2 0 (0.2)
Total Liabilities 12.7 17.4 11.1 9.1 22.1 18.8 18.6 23.6 25.5 44.4 38.9 36.8 41.6 43.5 28.4 33.3 30.9 35.7 34.4 12.6 13.2 13.3 4.7 2.9 0 0.2
EQUITY
Common Stock 5 K 34 K 16 K 7 K 4 K 15 K 58 K 22 K 0.2 99 K 71 K 66 K 57 K 52 K 40 K 31 K 26 K 22 K 18 K 17 K 17 K 17 K 15 K 15 K 0 0
Retained Earnings (480.5) (467.2) (446.9) (433.5) (425.3) (414.4) (401.7) (379.1) (357.0) (338.3) (300.9) (274.7) (242.4) (210.0) (182.5) (162.2) (132.1) (103.5) (78.0) (51.5) (49.4) (40.1) (27.1) (15.9) 0 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 1.2 1.4 1.3 1.0 0.7 0.3 (8.6) (8.0) (7.6) (6.9) (6.2) 4 K 14 K 16 K 32 K 26 K 0.2 0.3 0.2 0 0
Total Equity (1.3) 6.4 10.8 3.0 1.2 5.2 13.0 11.0 12.2 (5.7) 3.1 6.5 9.9 22.9 (3.7) (7.7) (9.4) (10.8) (6.2) 12.8 14.9 26.0 38.5 49.3 (6.1) 0.1
Total Liabilities and Equity 11.4 23.9 22.0 12.1 23.2 24.0 31.6 34.6 37.7 38.7 42.1 43.2 51.5 66.3 24.7 25.6 21.5 24.9 28.2 25.5 28.1 39.3 43.1 52.3 5.6 1.0
SHARES OUTSTANDING
Common Shares Outstanding 3.1 1.8 0.8 0.3 92.3 K 11.6 K 4.32 K 2.3 K 1.25 K 927 665 615 528 485 373 273 224 174 143 130 130 135 141 1.15 K 140 140